Dr. Abraham Palmer visited the Institute for Behavioral Genetics at the University of Colorado Boulder. He was invited to be the keynote speaker for a graduate student conference.
The title of his talk was, “Quantitative behavioral genetics in mice, rats, and humans,” which highlighted his contributions to the field of behavioral genetics.
Apurva and Abraham attended the Addiction Genetics and Epigenetics Data Jamboree, May 29-31 at the Oak Ridge National Laboratory in Oak Ridge, TN.
This workshop, co-sponsored by NIDA and the Oak Ridge National Laboratory, discussed challenge problems to integrate data across human and model organism genetics, genomics, and epigenetic studies of addiction.
Dr. Amanda Barkley-Levenson gave a talk titled, “Glyoxalase 1 involvement in ethanol reward sensitivity and ethanol withdrawal” at the International Behavioral and Neural Genetics Society meeting in Edinburgh, Scotland.
Dr. Abraham Palmer was featured in Triton magazine in the article, “The genetics of risk.” He discusses his recent article published in Nature Genetics.
Triton magazine is published by UC San Diego Alumni. It appears in print three times a year: fall, winter and spring.
Dr. Amanda Barkey-Levenson received the RSA Junior Investigator Travel Award for travel to the annual Research Society on Alcoholism meeting in Minneapolis, Minnesota on June 22nd-26th.
Dr. Sandra Sanchez-Roige was recently promoted from post-doctoral scholar to Assistant Professor in the Department of Psychiatry at UCSD. Funded by the TRDRP New Investigator Award, Sandra will derive psychiatric phenotypes from electronic health records from one of the largest biobanks in the US, BioVU, to perform genetic studies of substance use disorders. Sandra is also receiving funds from the Brain and Behavior Research Foundation (NARSAD Young Investigator Award) to validate some of the human genetic findings using animal models.
Amy Lee, an undergraduate student working under Dr. Amanda Barkley-Levenson, presented a poster titled, “Glyoxalase 1 inhibition is a potential novel therapeutic target in chronic ethanol withdrawal” at the annual Judd Symposium held at UCSD on April 15th. Other authors include Dr. Barkley-Levenson and Dr. Abraham Palmer.